For the Inventor, By the Inventor

Enter assignee name

Msd K.k.

USPTO Granted Patents = 47

CIPO Patents = 8

EPO Patents = 51

Forward Citations = 163

Loading Chart...

Loading Chart...

111 inventors (with patents filed for the assignee):

Tsuyoshi Nagase (9 out of 15 patents)

Toshihiro Sakamoto (8 out of 29 patents)

Hidetomo Furuyama (7 out of 14 patents)

4. Makoto Bamba (7 out of 13 patents)

5. Nobuhiko Kawanishi (7 out of 14 patents)

6. Nagaaki Sato (7 out of 19 patents)

7. Satoshi Sunami (6 out of 8 patents)

8. Kenji Niiyama (6 out of 17 patents)

9. Keiji Takahashi (6 out of 16 patents)

10. Mitsuru Ohkubo (6 out of 22 patents)

11. Toshiyuki Takahashi (6 out of 24 patents)

12. Teruyuki Nishimura (6 out of 15 patents)

13. Tomoharu Iino (6 out of 12 patents)

14. Yasuhiro Goto (5 out of 37 patents)

15. Yoshio Ogino (5 out of 21 patents)

Core Competencies:

Heteroaryl Quinazoline Derivatives

Dihydropyrazolopyrimidinone Derivatives

Inhibitors Of Akt Activity

Aminopyridine Derivatives

Combination Cancer Therapy

Long-Chain Fatty Acyl Elongase Inhibitor

Pyrimidopyrimidoindazole Derivative

Benzoxazinone Derivative

Sulfonyl-Substituted Derivatives

Spirochromanone Derivatives

Therapeutic Compounds

Aza-Substituted Spiro Derivatives

47 patents: Sort by Forward Citations

1. 8846700 - Heteroaryl quinazoline derivatives (2014-09-30),

2. 8791125 - Dihydropyrazolopyrimidinone derivatives (2014-07-29),

3. 8765789 - 2-pyridinecarboxamide derivatives (2014-07-01),

4. 8614221 - Inhibitors of Akt activity (2013-12-24),

5. 8609699 - Oxotetrahydrofuran-2-yl-benzimidazole derivative (2013-12-17),

6. 8592428 - Acetyl pyrrolidinyl indole derivative (2013-11-26),

7. 8575179 - Dihydropyrazolopyrimidinone derivatives (2013-11-05),

8. 8536193 - Inhibitors of AKT activity (2013-09-17),

9. 8524730 - Spirochromanone carboxylic acids (2013-09-03),

10. 8519136 - Aminopyridine derivatives having aurora a selective inhibitory action (2013-08-27),

11. 8507505 - Dihydropyrazolopyrimidinone derivative (2013-08-13),

12. 8492397 - Aminopyridine derivatives having Aurora A selective inhibitory action (2013-07-23),

13. 8481503 - Combination cancer therapy with an AKT inhibitor and other anticancer agents (2013-07-09),

14. 8455477 - Therapeutic compounds (2013-06-04),

15. 8436004 - Bicycloaniline derivative (2013-05-07),

MSD K.K. is a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA, and is a leading research-driven pharmaceutical company dedicated to improving health and well-being. MSD K.K. offers a wide range of innovative prescription medications, vaccines, and animal health products. With a commitment to discovering, developing, and providing healthcare solutions, MSD K.K. aims to make a meaningful impact on people's lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

47 Patents

#719 in Tokyo

#1,741 in Japan

#14,392 in the World

Msd K.k.

Forward Citations = 163

111 inventors:

Tsuyoshi Nagase (9 out of 15 patents)

Toshihiro Sakamoto (8 out of 29 patents)

Hidetomo Furuyama (7 out of 14 patents)

4. Makoto Bamba (7 out of 13 patents)

5. Nobuhiko Kawanishi (7 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…